Howard Robin Net Worth & Insider Trades

Howard Robin - President & CEO, Nektar Therapeutics

As of November 18, 2022

What is Howard Robin's Net Worth?

The current estimated net worth of Nektar Therapeutics's President & CEO, Howard Robin, is estimated to be about $98.09M . Howard Robin owns about 980,203 units of Nektar Therapeutics common stock. In the last 15 years at Nektar Therapeutics, Howard Robin has sold an estimated value of $101.08M worth.

What is Howard Robin's Past Insider Trading?

Howard Robin's largest purchase order was 600,000 units , worth over $8.71M on November 26, 2014. Howard Robin's largest sale order was 130,000 units , worth over $10.93M on May 3, 2018. In total, Howard Robin has made about 75 transactions over 15 years of their time at Nektar Therapeutics. Howard Robin usually trades in February, with the busiest year in 2016 and 2017. The most recent transaction was a sale order of 38,014 units , worth over $135.71K on November 18, 2022.

Ticker
Type
Value
Price per Share
Shares
Filing Date
No matching records found
1

What are Nektar Therapeutics's Past Insider Trades?

Nektar Therapeutics's most recent insider trade came on November 18, 2022 by Jonathan Zalevsky who sold 13,460 units worth $48.05K . In the last 19 years, insiders at Nektar Therapeutics have sold an estimated value of $295.13M and bought an estimated value of $84.98M worth of shares. Insider trading is most common in September, with the busiest year in 2017 and 2016. The most active traders at the company are Gil Labrucherie, SVP,  Howard Robin, President & CEO,  and Robert Chess, Director .

NEKTAR THERAPEUTICS Insider Trades

Date Range: All Time
Insider Names
Type
Value
Price per Share
Shares
Filing Date
No matching records found
1